COVID-19 trials registries data warehouse

 Return to trial list

Trial - RBR-3t9pkzt


Column Value
Trial registration number RBR-3t9pkzt
Full text link
Last imported at : July 16, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Guilherme ArĂȘas

Contact
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Guilhermepta@ufam.edu.br

Registration date
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2021-07-01

Recruitment status
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Blind label

Center
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

unclear

Study aim
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Long covid

Inclusion criteria
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Clinically stable individuals, residing in Manaus must have been diagnosed with COVID-19 by the polymerase chain reaction method (RT-PCR) for SARS-CoV-2, remained hospitalized and had discharged from the hospital. In addition, volunteers must present a pre-hospitalization medical history of clinical stability in the 4 months before hospitalization for COVID-19 and perception of dyspnea II and III by the Medical Research Council (MRC).

Exclusion criteria
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Volunteers undergoing pulmonary rehabilitation 6 months before the start of the study, pregnant women, previous medical history of respiratory diseases (COPD, asthma, idiopathic pulmonary fibrosis), arterial O2 saturation (SpO2) = 88% at rest, hypertension uncontrolled, cardiovascular (heart failure, hypertension, transplantation, and surgeries), history of use and abuse of illicit drugs, alcoholics, smokers, pacemakers and/or implantable defibrillators, oncologic, metabolic (diabetes) and decompensated, chronic-degenerative kidneys in progression and osteoarticular and cognitive that prevent the performance of the physical exercise. In addition, individuals who present claustrophobia to the use of the NIV mask for training or performing the cardiopulmonary test will be excluded.

Number of arms
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Universidade Federal do Amazonas

Inclusion age min
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

30

Inclusion age max
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

65

Countries
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Brazil

Type of patients
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients recovered from covid

Severity scale
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

0

primary outcome
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Improved V?O2 through cardiopulmonary test; distance walked in the 6-minute walk test; and quality of life through SF-36 values

Notes
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Arms
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 1043, "treatment_name": "Pulmonary rehabilitation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1674, "treatment_name": "Non invasive ventilation+pulmonary rehabilitation", "treatment_type": "Respiratory support+rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}]